Signal / reference entry

Semaglutide

Also listed as Wegovy

Start with the scope. Follow the sources. Use the reading note to examine how a claim is supported.

Reference fields

View sources

Approval labels are specific to a product, route, and use. Read the scope and limitations together.

Status for this entry
Approved product
Evidence label
Randomized evidence

Status as of

Product and use
Wegovy injection: weight management in eligible adults.
Route context
This entry covers subcutaneous Wegovy injection.
Mechanism
Activates the GLP-1 receptor.
Evidence
Randomized trials.
Limitations
Check other products separately.
Safety
Severe or persistent gastrointestinal symptoms: contact a clinician.

Sources for these reference fields

Read beyond the claim

A closer reading

Start with the sentence that caught your attention and follow its citation until you can identify the report being discussed. If the trail ends at another summary, keep track of that extra step. Then compare the original question with the claim that sent you looking. A link is useful only if it lets you inspect the relevant support; its presence alone does not resolve a mismatch. Record which part of the claim the report addresses and which part still needs an explanation. That creates a clear account of what you verified.

Questions to take to the source

  1. Which exact report sits at the end of this citation trail?
  2. What part of the original claim can I locate in that report?
  3. Does an intermediate summary add an interpretation that needs separate support?

Filed under

  • Metabolism

Topics organize the index; they do not describe a recommended use.

Sources

These references support the reference fields as a group. Follow each link to inspect its scope and wording.

  1. WEGOVY NLM · Checked
  2. Wegovy approval FDA · Checked

Educational reference material. No clinician review is claimed. This entry does not provide personal medical advice.